Teladoc Health, Inc. TDOC
NYSE
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -2.38% | -2.08% | -1.50% | -1.54% | -2.37% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -2.38% | -2.08% | -1.50% | -1.54% | -2.37% |
| Cost of Revenue | 1.60% | 2.19% | 2.49% | 2.71% | 1.02% |
| Gross Profit | -4.09% | -3.88% | -3.17% | -3.30% | -3.77% |
| SG&A Expenses | -8.69% | -7.24% | -5.39% | -4.94% | -2.02% |
| Depreciation & Amortization | 2.72% | 1.79% | 1.37% | -2.54% | -5.97% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -3.93% | -3.32% | -2.48% | -3.06% | -2.85% |
| Operating Income | 25.90% | 20.62% | 15.78% | 21.74% | 9.14% |
| Income Before Tax | 36.56% | 21.42% | 81.95% | 76.30% | 74.24% |
| Income Tax Expenses | 85.55% | 79.21% | -4.53% | -563.75% | -343.77% |
| Earnings from Continuing Operations | 30.76% | 14.45% | 83.09% | 79.99% | 77.23% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 30.76% | 14.45% | 83.09% | 79.99% | 77.23% |
| EBIT | 25.90% | 20.62% | 15.78% | 21.74% | 9.14% |
| EBITDA | 429.02% | 241.93% | 44.75% | 4.23% | -74.57% |
| EPS Basic | 32.74% | 16.88% | 83.75% | 80.61% | 77.85% |
| Normalized Basic EPS | 18.95% | 7.37% | 15.18% | 27.62% | 5.38% |
| EPS Diluted | 32.74% | 16.88% | 83.75% | 80.61% | 77.85% |
| Normalized Diluted EPS | 18.95% | 7.37% | 15.18% | 27.62% | 5.38% |
| Average Basic Shares Outstanding | 2.87% | 2.96% | 3.07% | 3.32% | 3.59% |
| Average Diluted Shares Outstanding | 2.87% | 2.96% | 3.07% | 3.32% | 3.59% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |